To characterize photoimmunotherapy-induced intratumoral immune responses in vivo, mice bearing CT26-EphA2 tumors received EphA2 photoimmunotherapy treatment, followed by tumor excision for flow cytometry analysis and characterization of intratumoral cells. This evidence concerns the gene DDX53 and neoplasm.